Key Financial Data Of Group

Renascience Inc. - Filing #7296926

Concept 2024-04-01 to
2024-09-30
As at
2024-09-30
As at
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2023-09-30
As at
2023-09-30
Key financial data of group
Business results of group
Ordinary profit (loss)
-92,045,000 JPY
-251,875,000 JPY
-94,343,000 JPY
Net assets
1,533,755,000 JPY
1,606,724,000 JPY
1,769,737,000 JPY
Total assets
1,957,093,000 JPY
2,088,833,000 JPY
2,242,852,000 JPY
Basic earnings (loss) per share
-5.74
-20.32
-7.50
Diluted earnings per share
Equity-to-asset ratio
0.784 xbrli:pure
0.769 xbrli:pure
0.789 xbrli:pure
Net cash provided by (used in) operating activities
-132,137,000 JPY
-230,519,000 JPY
-84,271,000 JPY
Net cash provided by (used in) investing activities
2,250,000 JPY
-1,567,000 JPY
JPY
Net cash provided by (used in) financing activities
9,476,000 JPY
46,500,000 JPY
46,500,000 JPY
Cash and cash equivalents
1,525,782,000 JPY
1,646,193,000 JPY
1,794,008,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.